Clinical Trials Browser

Phase 2 × INDUSTRY × Fenretinide × Clear all

NCT02495415 2019-07-23

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral